Copyright
©The Author(s) 2023.
World J Nephrol. Dec 25, 2023; 12(5): 168-181
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.168
Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.168
Table 3 Number of patients prescribed each antihypertensive class at baseline, organised by primary aetiology of chronic kidney disease at baseline
| Primary aetiology of CKD | Three or more1 | RAS blocker1 | Diure | Beta blocker1 | Alpha blocker1 | CCB (dihydro-pyridine)1 | CCB (non-dihydro-pyridine)1 | Central agents1 |
| Diabetes, n = 636 | 386 (61) | 463 (73) | 416 (65) | 239 (38) | 220 (35) | 281 (44) | 32 (5) | 53 (8) |
| Hypertension, n = 471 | 246 (52) | 294 (62) | 245 (52) | 210 (45) | 154 (33) | 222 (47) | 33 (7) | 21 (5) |
| Renovascular disease, n = 256 | 163 (64) | 142 (56) | 178 (70) | 121 (47) | 92 (36) | 122 (48) | 20 (8) | 27 (11) |
| Pyelonephritis, n = 200 | 40 (20) | 102 (51) | 54 (27) | 50 (25) | 23 (12) | 61 (31) | 4 (2) | 3 (2) |
| ADPKD, n = 197 | 66 (34) | 149 (76) | 69 (35) | 55 (28) | 40 (20) | 78 (40) | 2 (1) | 6 (3) |
| Tubulointerstitial nephritis, n = 116 | 9 (8) | 40 (35) | 18 (16) | 27 (23) | 8 (7) | 35 (30) | 3 (3) | 2 (20) |
| Glomerulonephritis, n = 375 | 171 (46) | 305 (81) | 174 (46) | 95 (25) | 73 (20) | 147 (39) | 9 (2) | 21 (6) |
| Vasculitis, n = 118 | 31 (26) | 61 (52) | 34 (29) | 35 (30) | 19 (16) | 40 (34) | 2 (2) | 1 (1) |
| Haematological disease, n = 31 | 8 (26) | 14 (45) | 9 (29) | 8 (26) | 4 (13) | 7 (23) | 0 | 1 (3) |
| Other/unknown aetiology, n = 830 | 263 (32) | 413 (50) | 328 (40) | 267 (32) | 146 (18) | 263 (32) | 29 (4) | 15 (2) |
- Citation: Chinnadurai R, Wu HHL, Abuomar J, Rengarajan S, New DI, Green D, Kalra PA. Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study. World J Nephrol 2023; 12(5): 168-181
- URL: https://www.wjgnet.com/2220-6124/full/v12/i5/168.htm
- DOI: https://dx.doi.org/10.5527/wjn.v12.i5.168